Patent · US Active

Combination of BI853520 with chemotherapeutic drugs

US12097200B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2023
Grant dateSep 24, 2024
Priority date
Expiry dateJul 5, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a use of BI853520 or a pharmaceutically acceptable salt thereof in preparing drugs for treating tumors in combination with chemotherapeutic drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.